View Older Stories View More Recent Stories

Feb 11, 2022 05:17PM Form SC 13G/A Verrica Pharmaceuticals Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 05:15PM Form SC 13G VectivBio Holding AG Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 05:10PM Form SC 13G/A VistaGen Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 05:07PM Form SC 13G/A Harpoon Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 05:04PM Form SC 13G/A Strongbridge Biopharma Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 05:03PM Form SC 13G Sonendo, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 05:03PM Form SC 13G/A Pandion Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 05:01PM Form SC 13G/A NeuroPace Inc Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:59PM Form SC 13G/A Theravance Biopharma, Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:55PM Form SC 13G/A OTONOMY, INC. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:55PM Form SC 13G Protara Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:51PM Form SC 13G RxSight, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:48PM Form SC 13G/A Mereo Biopharma Group Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:48PM Form SC 13G/A MeiraGTx Holdings plc Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:47PM Form SC 13G/A Crinetics Pharmaceutical Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:47PM Form SC 13G Jounce Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:41PM Form SC 13G/A Larimar Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:40PM Form SC 13G Gracell Biotechnologies Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:40PM Form SC 13G/A FLUIDIGM CORP Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:40PM Form SC 13G/A Forte Biosciences, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:32PM Form SC 13G CATALYST BIOSCIENCES, Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:22PM Form SC 13G/A Applied Therapeutics Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:21PM Form SC 13G/A Aeglea BioTherapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 11, 2022 04:16PM Form SC 13G/A Adverum Biotechnologies, Filed by: ORBIMED ADVISORS LLC
Feb 8, 2022 08:00AM Congruence Therapeutics Inc. Announces US$50 million Series A Financing to Advance Platform Targeting Diseases of Protein Misfolding
Feb 2, 2022 04:34PM Form SC 13D/A Sierra Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
Jan 28, 2022 09:23PM Form 4 Sierra Oncology, Inc. For: Jan 26 Filed by: ORBIMED ADVISORS LLC
Jan 27, 2022 05:24PM Form 4 89bio, Inc. For: Jan 25 Filed by: OrbiMed Advisors Israel II Ltd
Jan 24, 2022 04:44PM Form 4 Passage BIO, Inc. For: Jan 20 Filed by: ORBIMED ADVISORS LLC
Jan 20, 2022 06:04PM Form 4 Passage BIO, Inc. For: Jan 14 Filed by: ORBIMED ADVISORS LLC
Jan 13, 2022 07:38PM Form 4 Passage BIO, Inc. For: Jan 11 Filed by: ORBIMED ADVISORS LLC
Jan 6, 2022 07:00AM Odyssey Therapeutics Acquires Rahko, a Quantum Machine Learning Company
Dec 30, 2021 09:00PM Form 4 Janux Therapeutics, Inc. For: Dec 29 Filed by: ORBIMED ADVISORS LLC
Dec 30, 2021 04:05PM SINOVAC Reports Unaudited First Half of 2021 Financial Results
Dec 17, 2021 05:09PM Form SC 13D/A Janux Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
Dec 14, 2021 05:30PM Form SC 13D/A Adicet Bio, Inc. Filed by: ORBIMED ADVISORS LLC
Dec 9, 2021 02:26PM Antigua Court of Appeal Rules in Favor of SINOVAC, Upholds 2018 Judgment
Dec 7, 2021 07:00AM Odyssey Therapeutics Announces $218 Million Series A Financing to Advance Next Generation Inflammation and Oncology Medicines
Dec 7, 2021 07:00AM Emergence Therapeutics raises €87 million Series A financing to advance Nectin-4 ADC
Dec 7, 2021 02:00AM Emergence Therapeutics raises €87 million Series A financing to advance Nectin-4 ADC
Dec 6, 2021 07:00AM Cyrus Biotechnology Announces $18M Financing and Acquisition of Orthogonal Biologics to Form an Integrated Software-Driven Pre-Clinical-Stage Drug Discovery Firm
Nov 18, 2021 05:10PM Form SC 13D/A Theseus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Nov 18, 2021 04:56PM Form SC 13D/A Acutus Medical, Inc. Filed by: ORBIMED ADVISORS LLC
Nov 17, 2021 04:10PM Form 4 Tricida, Inc. For: Nov 15 Filed by: ORBIMED ADVISORS LLC
Nov 17, 2021 08:15AM Alpheus Medical CLOSES $16M IN Series A Financing for novel glioma BRAIN cancer treatment
Nov 15, 2021 04:13PM Form 13F-HR ORBIMED ADVISORS LLC For: Sep 30
Nov 12, 2021 05:06PM Form SC 13D/A ALPINE IMMUNE SCIENCES, Filed by: ORBIMED ADVISORS LLC
Nov 9, 2021 05:37PM Form SC 13D/A Compass Therapeutics, Filed by: ORBIMED ADVISORS LLC
Nov 8, 2021 09:06PM Form 4 Compass Therapeutics, For: Nov 04 Filed by: ORBIMED ADVISORS LLC
Nov 5, 2021 04:27PM Form SC 13D/A Sierra Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
View More Recent Stories View Older Stories